Radiation-induced heart disease (RIHD) is a potentially severe side effect of radiotherapy of thoracic and chest wall tumors. Despite advances in radiation delivery and treatment planning technology, cardiac radiation toxicity remains a key consideration in thoracic radiotherapy. Hence, research is urgently needed to elucidate biological mechanisms and identify potential targets for intervention. Our previous pre-clinical studies in a mast cell-deficient rat model have shown that, contrary to what had been the prevailing assumption, mast cells play a predominantly protective role in RIHD. The overall goal of this project is to uncover the role of three mast cell targets in RIHD. For this purpose, genetic animal models and pharmacological interventions will be used to define the involvement of 1) Proteinase-Activated Receptor (PAR)-2, the receptor that mediates cellular effects of mast cell proteinases;2) bradykinin, a cardioprotective hormone that is formed by mast cell proteinases;and 3) the cardioprotective sensory neuropeptide calcitonin gene-related peptide (CGRP), as part of the neuroimmune interactions that are known to alter cardiac function and disease. Functional, structural, cellular and molecular manifestations of RIHD will be measured after local heart irradiation. These in vivo experiments will be the first to provide mechanistic insight into the protective effects of mast cells in RIHD, providing critical pre-clinical data as a basis for future development of intervention strategies, thereby enhancing the efficacy and safety of thoracic radiotherapy.
Radiation-induced heart disease (RIHD) is a severe side effect of radiotherapy of thoracic and chest wall tumors. This project will investigate underlying mechanisms of RIHD and will provide critical pre-clinical data as a basis for future development of strategies aimed at reducing RIHD, thereby enhancing the efficacy and safety of thoracic radiotherapy.
|Pathak, Rupak; Bachri, Abdel; Ghosh, Sanchita P et al. (2016) The Vitamin E Analog Gamma-Tocotrienol (GT3) Suppresses Radiation-Induced Cytogenetic Damage. Pharm Res 33:2117-25|
|Ramadan, Samy S; Sridharan, Vijayalakshmi; Koturbash, Igor et al. (2016) A priming dose of protons alters the early cardiac cellular and molecular response to (56)Fe irradiation. Life Sci Space Res (Amst) 8:8-13|
|Sridharan, Vijayalakshmi; Thomas, Chanice J; Cao, Maohua et al. (2016) Effects of local irradiation combined with sunitinib on early remodeling, mitochondria, and oxidative stress in the rat heart. Radiother Oncol 119:259-64|
|Boerma, Marjan; Sridharan, Vijayalakshmi; Mao, Xiao-Wen et al. (2016) Effects of ionizing radiation on the heart. Mutat Res 770:319-327|
|Koturbash, Igor; Miousse, Isabelle R; Sridharan, Vijayalakshmi et al. (2016) Radiation-induced changes in DNA methylation of repetitive elements in the mouse heart. Mutat Res 787:43-53|
|Boerma, Marjan; Nelson, Gregory A; Sridharan, Vijayalakshmi et al. (2015) Space radiation and cardiovascular disease risk. World J Cardiol 7:882-8|
|Sridharan, Vijayalakshmi; Tripathi, Preeti; Aykin-Burns, Nukhet et al. (2015) A tocotrienol-enriched formulation protects against radiation-induced changes in cardiac mitochondria without modifying late cardiac function or structure. Radiat Res 183:357-66|
|Pathak, Rupak; Shao, Lijian; Ghosh, Sanchita P et al. (2015) Thrombomodulin contributes to gamma tocotrienol-mediated lethality protection and hematopoietic cell recovery in irradiated mice. PLoS One 10:e0122511|
|Lieblong, Benjamin J; Sridharan, Vijayalakshmi; Srivastava, Anup K et al. (2015) Role of the bradykinin B2 receptor in a rat model of local heart irradiation. Int J Radiat Biol 91:634-42|
|Boerma, Marjan; Singh, Preeti; Sridharan, Vijayalakshmi et al. (2015) Effects of Local Heart Irradiation in a Glutathione S-Transferase Alpha 4-Null Mouse Model. Radiat Res 183:610-9|
Showing the most recent 10 out of 20 publications